Three Arch Management IV, L.L.C.
Insider CIK 1365429 · CNCE Director, 10% owner · NVRO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 4,916 | $19.57 | $96.2K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 113 | $19.57 | $2.2K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 265 | $19.57 | $5.2K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-16 | 2015-12-16 | 5,066 | $19.57 | $99.1K | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 589 | $20.10 | $11.8K | 113 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 26,697 | $20.10 | $536.6K | 5,066 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 1,392 | $20.10 | $28.0K | 265 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-15 | 2015-12-16 | 25,894 | $20.10 | $520.5K | 4,916 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 42 | $20.09 | $844 | 702 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 1,919 | $20.09 | $38.6K | 31,763 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 1,861 | $20.09 | $37.4K | 30,810 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-12-14 | 2015-12-16 | 100 | $20.09 | $2.0K | 1,657 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 56,938 | $18.22 | $1.04M | 32,671 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 3,062 | $18.22 | $55.8K | 1,757 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 58,704 | $18.22 | $1.07M | 33,682 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-09-10 | 2015-09-14 | 1,296 | $18.22 | $23.6K | 744 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 298,929 | $15.70 | $4.69M | 89,609 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 16,071 | $15.70 | $252.3K | 4,819 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 6,805 | $15.70 | $106.8K | 2,040 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-18 | 2015-08-18 | 308,195 | $15.70 | $4.84M | 92,386 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 63,596 | $16.32 | $1.04M | 400,581 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 61,684 | $16.32 | $1.01M | 388,538 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 3,316 | $16.32 | $54.1K | 20,890 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-14 | 2015-08-18 | 1,404 | $16.32 | $22.9K | 8,845 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 45,112 | $16.75 | $755.6K | 464,177 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 43,755 | $16.75 | $732.9K | 450,222 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 2,352 | $16.75 | $39.4K | 24,206 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-13 | 2015-08-17 | 996 | $16.75 | $16.7K | 10,249 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 2,494 | $14.49 | $36.1K | 26,558 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 47,837 | $14.49 | $693.2K | 509,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 1,056 | $14.49 | $15.3K | 11,245 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 46,398 | $14.49 | $672.3K | 493,977 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 2,494 | $17.49 | $43.6K | 26,558 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 46,398 | $17.49 | $811.5K | 493,977 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 47,837 | $17.49 | $836.7K | 509,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2015-08-12 | 2015-08-14 | 1,056 | $17.49 | $18.5K | 11,245 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 244,600 | $12.29 | $3.01M | 557,126 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 5,400 | $12.29 | $66.4K | 12,301 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 1,276,263 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 1,958,738 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 2,162,814 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 28,180 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 47,755 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 43,249 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,467,595 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 32,405 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 391,359 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,956,794 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 8,641 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 43,206 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 346,335 | — | $0 | 631,195 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 5,735 | — | $0 | 6,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 101,264 | $14.00 | $1.42M | 801,726 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 2,236 | $14.00 | $31.3K | 17,701 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 69,267 | — | $0 | 700,462 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 259,751 | — | $0 | 284,860 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 1,529 | — | $0 | 15,465 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 7,647 | — | $0 | 13,936 | SEC↗ |